Becker, JC; Leiter-Stoppke, U; Gesierich, A; Ulrich, C; Kähler, KC; Pfoehler, C; Gambichler, T; Wolf, I; Herbst, R; Meier, F; Hassel, JC; Meiss, F; Mohr, P; Terheyden, P; Zouboulis, C; Stang, A; Galetzka, W; Ugurel-Becker, S; Lodde, GC
Only early adjuvant radiotherapy, particularly of the tumor bed rather than the lymph node region, improves prognosis in Merkel cell carcinoma: Results from the prospective German MCC registry
ANN ONCOL. 2024; 35: S744-S744.
Doi: 10.1016/j.annonc.2024.08.2136
Web of Science
FullText
FullText_MUG
Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Hauschild, A; Stadler, R; Berking, C; Pehamberger, H; Kopp-Schneider, A; Becker, JC
Ex-vivo sensitivity-directed combination chemotherapy compared to DTIC monochemotherapy in chemo-naive advanced metastastic melanoma (ChemoSensMM): a multicenter randomized phase-3 DeCOG trial
J DTSCH DERMATOL GES. 2015; 13: 18-19.-25. Deutscher Hautkrebskongress; Sept 10-12, 2015; München.
[Oral Communication]
Web of Science
Schrama, D; Groesser, L; Haffner, C; Ugurel, S; Pastrana, D; Buck, C; Cerroni, L; Theiler, A; Becker, JC
Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor induced epithelial proliferations
J DTSCH DERMATOL GES. 2014; 12: 42-42.-Deutscher Hautkrebskongress und ADO-Jahrestagung; SEP 11-13 2014; Frankfurt am Main, GERMANY.
[Poster]
Web of Science
Becker, J; Pflugfelder, A; Trefzer, U; Ugurel, S; Pfohler, C; Kellner, Y; Beissert, S; Kahler, K; Mohr, P; Zouboulis, C; Zimmer, L; Belloni, B; Berking, C; Schadendorf, D;
Merkel Cell Carcinoma Register of the ADO - the first Evaluation.
J DTSCH DERMATOL GES. 2013; 11(9):909-910.-Deutscher Hautkrebskongress; September, 2013; Essen, D.
[Oral Communication]
Web of Science
Schrama, D; Ugurel, S; Schadendorf, D; Becker, JC;
No association of STAT3 rs4796793 SNP with response to IFN alpha therapy in patients with metastatic melanoma.
EXP DERMATOL. 2013; 22(3):E22-E22.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY.
[Poster]
Web of Science
Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pfohler, C; Schiller, M; Hauschild, A; Hein, R; Kampgen, E; Kellner, I; Leverkus, M; Becker, J; Strobel, P; Schadendorf, D.
Neo-adjuvant Therapy of Dermatofibrosarcoma protuberans with Imatinib: A multicenter Phase II Study of the ADO.
J DTSCH DERMATOL GES. 2013; 11(9):909-909.-ADO-Tagung; September, 2013; Essen, D.
[Oral Communication]
Web of Science
Aigner, B; Richtig, E; Becker, J; Marterer, R; Niederkom, A; Lingitz, H; Ugurel, S;
Partial Remission of metastatic Mucosal melanoma receiving palliative therapy with Trofosfamide.
J DTSCH DERMATOL GES. 2012; 10(9):695-695.-ADO; Hannover.
[Poster]
Web of Science
Livingstone, E; Eigentler, T; Windemuth-Kieselbach, C; Rompel, R; Trefzer, U; Nashan, D; Ugurel, S; Gesierich, A; Kahler, K; Schadendorf, D;
Quality Assurance Project melanoma: Results of the Interim Survey 2 years after Initial diagnosis.
J DTSCH DERMATOL GES. . 2012; 10(9):678-678.
[Poster]
Web of Science
Aigner, BA; Richtig, E; Becker, JC; Ugurel, S
Partielle Remission eines ausgedehnt fernmetastasierten Schleimhautmelanoms unter palliativer oraler Chemotherapie mit Trofosfamid
Abstractband der ÖGDV 2011. 2011; -Jahrestagung der ÖGDV in Linz; NOV 11-13, 2011; Linz, AUSTIRA.
[Poster]
Degen, A; Weichenthal, M; Ugurel, S; Trefzer, U; Gauwerky, K; Garbe, C; Egberts, F; Frey, L; Hauschild, A; Gutzmer, R
Cutaneous Side Effects of combination Therapy with Sorafenib and Peginterferon - an Evaluation of the SoraPeg Study of the ADO
J DTSCH DERMATOL GES. . 2011; 9(9):779-779.-21. Deutscher Hautkrebs-Kongress 2011 und ADO Jahrestagung; SEP 15-17, 2011; Weimar, GERMANY.
[Poster]
Web of Science
Heinemann, A; Sucker, A; Steinle, A; Eberle, J; Ugurel, S; Schadendorf, D; Paschen, A
Connecting expression of the immunological cell stress indicator ULBP2 to the tumor suppressor activity of p53
EXP DERMATOL. . 2011; 20(2):P117--38th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); FEB 17-19, 2011; Tuebingen, GERMANY.
[Poster]
Web of Science
Justich, A; Niederkorn, A; Tilz, H; Massone, C; Richtig, E; Becker, J; Ugurel, S
Regression of a case of complete Paraplegia due to multiple Vertebral Body Metastases of a Melanoma being treated by BRAF-Inhibitor Vemurafenib
J DTSCH DERMATOL GES. 2011; 9(9):786-786.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland.
[Poster]
Web of Science
Niederkorn, A; Tilz, HE; Justich, A; Richtig, E; Ugurel, S; Becker, J
Response of an inoperative Relapse of a primary cutaneous large B-Cell-Lymphoma with endonasal Infiltration during Chemotherapy with pegylated liposomal Doxorubicine in Combination with Rituximab.
J DTSCH DERMATOL GES. 2011; 9(9):787-787.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland.
[Poster]
Web of Science
Richtig, E; Ugurel, S; Niederkorn, A; Justich, A; Tilz, H; Becker, J
Onset and rapid Progression of Vitiligo in a Patient with metastatic malignant Melanoma under Ipilimumag Therapy - possibly triggered by an increase in ACTH Process?
J DTSCH DERMATOL GES. 2011; 9(9):784-784.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland.
[Poster]
Web of Science
Richtig, E; Ugurel, S; Niederkorn, A; Justich, A; Tilz, H; Becker, J
Increase of Pancreatic Enzymes and of the Cortisol Levels in Patients with metastatic Melanoma under a Therapy with Ipilimumab
J DTSCH DERMATOL GES. 2011; 9(9):784-784.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland.
[Poster]
Web of Science
Tilz, H; Inzinger, M; Richtig, E; Massone, C; Ugurel, S; Niederkorn, A; Aigner, BA, Becker, JC
Pulmonale Sarkoidose nach adjuvanter Interferontherapie eines malignen Melanoms
Abstractband der ÖGDV 2011. 2011; -Jahrestagung der ÖGDV in Linz; NOV 11-13, 2011; Linz, AUSTRIA.
[Poster]
Tilz, HE; Niederkorn, A; Justich, A; Prettenhofer, U; Massone, C; Richtig, E; Becker, J; Ugurel, S
Successful Therapy of a Stewart Treves Angio Sarcoma by way of Radiation and Paclitaxel
J DTSCH DERMATOL GES. 2011; 9(9):789-789.
[Poster]
Web of Science
Heinemann, A; Sucker, A; Moll, I; Steinle, A; Schadendorf, D; Becker, J; Ugurel, S; Paschen, A
The Role of ULBP2 in Melanoma: Clinical Significance and Regulation.
J DTSCH DERMATOL GES. 2010; 8(9):749-749.-20. Deutscher Hautkrebskongress und ADO Jahrestagung ; Sep 23-25, 2010; Kiel, Germany .
[Poster]
Web of Science
Willmes, C; Kumar, R; Becker, JC; Schrama, D; Ugurel, S
Identification of SerpinB1 as a novel predictive molecular marker for chemosensitivity in melanoma
link auf der ADF Homepage. 2010; -37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); Feb 18-20; Lübeck, GERMANY.
[Poster]
FullText
Baumann, R; Ritter, C; Menaa, F; Houben, R; Synwoldt, P; Wischhusen, J; Schrama, D; Ugurel, S; Becker, JC
Melanoma cells with characteristic of cancer stem cells
Journal der Deutschen Dermatologischen Gesellschaft. 2009; 7(9):825-854.-5. Deutscher Hautkrebskongress und 19. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO) ; Sep 24-26; Köln, GERMANY.
[Poster]
Schrama, D; Scherer, D; Schneider, M; Zapatka, M; Ugurel, S; Kumar, R; Becker, JC
XPG D1104H and XPD K751Q polymorphisms are independent prognostic factors for melanoma
link auf der Homepage der ADF2009; -36th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); Mar 5-7, 2009; Heidelberg, GERMANY.
[Poster]
FullText
Willmes, C; Kumar, R; Becker, JC; Schrama, D; Ugurel, S
Identifikation von prädiktiven Biomarkern der ex-vivo Chemosensitivität und des klinischen Chemotherapieerfolgs beim malignen Melanom.
Journal der deutschen dermatologischen Gesellschaft DOI: 10.1111/j.1610-0387.2009.07201.x. 2009; 7(9):825-854.-5. Deutscher Hautkrebskongress und
19. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO); SEP 24-26; Köln, GERMANY.
[Oral Communication]